Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 3.98% of ELOX shares are held by financial institutions. GROUP ONE TRADING, L.P. is the top corporate investor, holding 0 shares valued at -. A 0% stake in Eloxx Pharmaceuticals, Inc. is owned by the company. BNP PARIBAS ARBITRAGE, SNC owns 0 shares valued at -, which translates its holding of 0% of the stake in the company.
Among the ELOX insiders holding of 5.82% of the stake in company, FORBES CHRISTOPHER, , holds the largest shares of 12.76M. SHABTAI GILAD, 10 percent owner, is the second largest ELOX insider with ownership of 3.35M shares. KLEIJWEGT MARTIJN, director, stands third with possession of 2.95M shares of that stake.
| Insiders | Designation | Shares Held |
|---|
| FORBES CHRISTOPHER | | 12.76M |
| SHABTAI GILAD | 10 percent owner | 3.35M |
| KLEIJWEGT MARTIJN | director | 2.95M |
| STALDER RUEDI | director | 2.33M |
| WAKSAL HARLAN | director | 1.9M |
| FROST PHILLIP MD ET AL | | 1.6M |
| KARIV TOMER | director | 616.59K |
| NUSSBAUM RAN | director | 616.59K |
| PONTIFAX MANAGEMENT 4 G.P. (2015) LTD. | 10 percent owner | 616.59K |
| RECTOR DAVID | director | 352.79K |
| PAREKH RAJESH B | director | 171.81K |
| BRACA JOHN N | director | 55.17K |
| GEFFKEN DANIEL E. | INTERIM CFO | 50K |
| WARD ROBERT | Chief Executive Officer | 15K |
| VAN HULST JACK | President and CEO | 5.81K |
| WEAVER GREGORY L | Chief Financial Officer | 4.5K |
| AVNUR ZAFRIRA | director | 2.26K |
| BROWNE LESLIE J | President and CEO | 1.29K |
